The medical device industry in the US is in turmoil, as approval times for new products have lengthened and fewer products are being approved. As a result, innovation is suffering.
Industry participants believe that the European approval process is far superior. A recent survey by Stanford University found that, on average, the time taken from first communication to approval for lower risk products was 31months in the US and seven months in Europe.
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine